Clinical Trials Directory

Trials / Unknown

UnknownNCT02983747

Autologous Platelet Rich Plasma on Low Back Pain

Autologous Platelet Rich Plasma in Ultrasound Guided Intervertebral Disk Injection Therapy for Chronic Low Back Pain

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
Shanghai Changzheng Hospital · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of autologous platelet-rich plasma (PRP) injection therapy for low back pain patients. Our hypothesis is that PRP will reduce the pain feeling and benefit for restore of the intervertebral disk.

Conditions

Interventions

TypeNameDescription
OTHERPRP Treatment(P)Ultrasound(Philips® iU22 ultrasound system) guided intra-disk injection using 2 ml of platelet rich plasma, containing 0.2 ml of calcium chloride(SINE®, SHANGHAI XINYI PHARMACEUTIAL Co . Ltd .) per treatment
DRUGMedication Treatment(Loxoprofen Sodium tablets,M)Loxoprofen Sodium tablets(LOXONNIN®, DAICHI SANKYO PHARMACEUTIAL (SHANGHAI) Co . Ltd .),P.O., 60mg, three times a day

Timeline

Start date
2019-11-01
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2016-12-06
Last updated
2022-05-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02983747. Inclusion in this directory is not an endorsement.